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The interphotoreceptor matrix (IPM) is a highly organized structure with interconnected domains sur-
rounding cone and rod photoreceptor cells and extends throughout the subretinal space. Based on
known roles of the extracellular matrix in other tissues, the IPM is thought to have several prominent
functions including serving as a receptor for growth factors, regulating retinoid transport, participating in
cytoskeletal organization in surrounding cells, and regulation of oxygen and nutrient transport. In
addition, a number of studies suggest that the IPM also may play a signiﬁcant role in the etiology of
retinal degenerative disorders. In this review, we describe the present knowledge concerning the
structure and function of the IPM under physiological and pathological conditions.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The extracellular matrix (ECM) is the non-cellular component
existing within all tissues and organs, and provides not only
structural support for the cellular constituents but also initiates
important biochemical events that are required for tissue
morphogenesis, differentiation and homeostasis (Frantz et al.,
2010; Jarvelainen et al., 2009). In the retina, the ECM is divided
into two separate entities; the interphotoreceptor matrix (IPM) and
the retinal ECM surrounding other cells in the retina that are be-
tween the RPE and photoreceptor outer segments (Al-Ubaidi et al.,eration; AVMD, adult-onset
brane; BMD, Best macular
, extracellular matrix; HA,
eoglycan; IPM, interphotor-
nding protein; MMP, matrix
d factor; PNA, peanut agglu-
gmented epithelium; SPACR,
, tissue inhibitor of metal-
or; VMD, vitelliform macular
logy, Akita University School
awa).
r Ltd. This is an open access article2013). The interphotoreceptor matrix (IPM) occupies the subretinal
space between the photoreceptor cells and the retinal pigmented
epithelium (RPE). The IPM is quite different from typical extracel-
lular matrices (ECMs) that have been extensively studied in other
tissues (Bridges, 1985). For many years, the IPM was considered
only as an amorphous ground substance of unknown signiﬁcance
(Henle, 1855; Berman, 1969). Sidman (1958), using freeze-
substitution methodology, demonstrated that the IPM was specif-
ically stained with alcian blue at the light microscopic level. Ul-
trastructural characterization of the IPM was performed
(Fernandez-Moran, 1961; R€ohlich, 1970; Feeney, 1973) cytochemi-
cally using ruthenium red, colloidal iron, phosphotungstic acid, and
silver methenamine. Yamada (1985) employed a rapid-freezing
technique to demonstrate that the IPM of unﬁxed bullfrog retinas
was composed of ﬁlamentous and granular components.
Although the ultrastructure of the IPM was documented, there
was little information relating to compartmentalization of the IPM
between adjacent photoreceptor cell types (Hageman and Johnson,
1991). The ﬁrst evidence of a speciﬁc IPM microenvironment
around cone photoreceptor cells was presented by Blanks and
Johnson (1984). They described a peanut agglutinin (PNA)-bind-
ing domain of the IPM surrounding cone photoreceptor cells
(Fig. 1). On the other hand, wheat germ agglutinin (WGA)-bindingunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Fluorescence micrograph of a meridional section of acrylamide-embedded human eye demonstrating the binding of FITC-PNA. Regions associated with cone, but not rod,
photoreceptor inner (IS) and outer segments (OS) are speciﬁcally labeled. Weak labeling is detected in discrete patches associated with cone photoreceptor synaptic pedicles
(arrowheads) within the outer synaptic layer (OSL). Diffuse labeling of the inner synaptic layer (ISL) is also apparent. 2. Nomarski differential interference contrast (A) and ﬂuo-
rescence (B) micrographs of the same meridional section of acrylamide embedded monkey (Macaca fascicularis) retina exposed to FITC-PNA. Regions devoid of cellular constituents
(asterisks) are visible surrounding cone photoreceptor inner (IS) and outer (OS) segments in (A). These cylindrical components within the interphotoreceptor matrix are responsible
for the majority of cone-speciﬁc PNA binding, as seen in the ﬂuorescence micrograph of the same ﬁeld (B). These cone matrix sheaths extend from the outer limiting membrane
(arrows) through the subretinal space (SS). Regions occupied by inner (IS) and outer (OS) segments show reduced levels of ﬂuorescence. 3. Fluorescence (A) and Nomarski dif-
ferential interference contrast (B) micrographs of an intact cone extracellular matrix sheath isolated from porcine retina following exposure to FITC-PNA. It is of the same di-
mensions as the cone matrix sheaths identiﬁed in sectioned retinae, as well as having similar PNA-binding characteristics. The regions previously occupied by the now absent cone
inner and outer segments can be identiﬁed in the ﬂuorescence micrograph (arrows in A).
These ﬁgures are the copy of Figs. 1e3 of the manuscript by Johnson et al., 1986. (by courtesy and approval of the Association for Research in Vision and Ophthalmology as the
copyright holder)
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receptor cells, but were virtually absent in the IPM surrounding
cone photoreceptor cells (Sameshima et al., 1987; Fariss et al., 1997).
These differences revealed by lectin cytochemistry raised further
questions about the function of the IPM.
One functional role of the IPM is retinal adhesion to the RPE (Yao
et al., 1994; Hageman et al., 1995; Marmor et al., 1994; Lazarus and
Hageman,1992). In addition, characteristic changes in the IPM have
been reported in murine models of retinal degeneration (Bridges,
1985; LaVail et al., 1981). A number of studies suggest that the
IPM may, indeed, play a signiﬁcant role in the etiology of photo-
receptor degeneration in some species (Bridges, 1985; LaVail et al.,
1985; Mieziewska et al., 1993a,b; Mieziewska, 1996; Hagstrom
et al., 1999). As postulated for the ECM (Gardiner, 2011; Rhodes
and Simons, 2007; Sprenger et al., 2010), the IPM may have
several important activities including providing receptors for
growth factor presentation (Hageman et al., 1991), retinoid trans-
port, cytoskeleton arrangement (Gardiner, 2011), and the transport
regulation of oxygen, and nutrients to the photoreceptor cells
(Rhodes and Simons, 2007).
In this review, we describe our current understanding of the
structure and function of the IPM surrounding retinal photore-
ceptor cells under physiological and pathological conditions.2. Molecular composition of the IPM
Basement membrane (BM) is a basic form of the ECM. The main
components of the BM are proteoglycans (heparan sulfate, chon-
droitin sulfate, and keratin sulfate proteoglycans), hyaluronan (HA),
ﬁbers (collagen and elastin), and other proteins such as ﬁbronectin,
ﬁbrillin, laminins, and ﬁbulins (Tran et al., 2005; Hubmacher and
Apte, 2013). Minor components of the BM include growth factors
(Schultz and Wysocki, 2009), immune mediators such as comple-
ment system components (e.g., complement factor H and vitro-
nectin) (Zipfel, 2001), chemokines (Patel et al., 2001), extracellular
proteases including matrix metalloproteinases (MMPs) (Mott and
Werb, 2004), acid phosphatase (Jacob, 1973), cyclic guanosine
monophosphate phosphodiesterase (cGMPP) (Miller et al., 2011)],
and their regulators that allow the restructuring of the BM (for
review, see the article by Mecham, 2012).
Unlike typical BM, the IPM lacks a collagenous meshwork, and
neither laminin nor ﬁbronectin are major components (Adler and
Klucznik, 1982; Kohno et al., 1983; Hageman and Johnson, 1991).
In the IPM, multiple factors contribute to its function. Most IPM
components appear to be synthesized by either the RPE or photo-
receptor cells (Adler and Severin, 1981).
In this chapter, we examine the molecular composition of the
Table 1
Comparison of the ECM and IPM components.
Proteins Extracellular matrix Interphotoreceptor matrix
References References
1 Fibrous protein Fibrous protein
Collagen I Alberts et al., 2007 Fibulin Marmorstein et al., 2002,
Hubmacher and Apte, 2013
Collagen III Alberts et al., 2007
Elastin Alberts et al., 2007
Fibulin du Plooy et al., 2014
Fibrillin Hubmacher et al., 2014
2 Adhesive glycoprotein Adhesive glycoprotein
Vitronectin Hayman et al., 1983
Tenascin Trebaul et al., 2007
Nidogen Timpl et al., 1984
Fibronectin Pankov and Yamada, 2002,
Smith et al., 2007
Fibronectin Hauck et al., 2005
Laminin Tran et al., 2005, Alberts et al., 2007 Laminin Hauck et al., 2005
Thrombospondin Hauck et al., 2005
3 Enzymes Enzymes
Matrix metalloprotease (MMP) Mott and Werb, 2004 MMP Jones et al., 1994,
Plantner and Quinn, 1997
Tissue inhibitor of
metalloprotease (TIMP)
Cruz-Munoz and Khokha, 2008 TIMP Padgett et al., 1997,
Plantner and Quinn, 1997
Cyclic guanosine monophosphate
phosphodiesterase (cGMPP)
Miller et al., 2011 cGMPP Barbehenn et al., 1985
b-glucuronidase Adler, 1989
Acid phosphatase Jacob, 1973 Acid phosphatase Adler, 1989
Cathepsin D Schmidt et al., 1988
Other acid hydrolase Adler and Martin, 1983;
Adler, 1989
(beta-galactosidase,
N-acetyl-beta-glucosaminidase,
a-fucosidase, b-glucuronidase,
a-glucosidase, a-mannosidase,
b-glucosidase, acid lipase）
Arylsurfatase Hayasaka et al., 1981
Neuron-speciﬁc enolase Li et al., 1995
4 Growth factors Growth factors
Tumor-growth factor (TGF-b) Schultz and Wysocki, 2009 TGF-b Tan et al., 2009
Platelet-derived growth factor (PDGF) Gospodarowicz et al., 1983 PEDF Tombran-Tink et al., 1992;
Becerra et al., 2004)
Fibroblast growth factor (FGF) Schultz and Wysocki, 2009 FGF Hageman et al., 1991
Discoidin domain receptor (DDR) Carafoli and Hohenester, 2013
Vascular endothelial growth factor (VEGF) Senger et al., 2009
Inhibin Ying et al., 1995
5 Chemokine Chemokine
CCL21 Patel et al., 2001
CCL17 Patel et al., 2001
CCL5 Patel et al., 2001
6 Hyaluronan-binding proteins Hyaluronan-binding proteins
Versican Zimmermann and Ruoslahti, 1989 Sialoprotein associated with
cones and rods (SPACR)
Acharya et al., 1998
Aggrecan Wilson et al., 2009 Oxygen-regulated photoreceptor
protein (ORP)
Pierce et al., 1999
Glial HA-binding protein Bignami et al., 1993
7 Others Others
Complement factor H (CFH) Zipfel, 2001 Complement factor H (CFH) Chen et al., 2007
Mucin Adler and Kulcznik, 1982,
Plantner et al., 1998a;
Plantner, 1992b
IRBP Wortman and Freeman,
1962, Pfeffer et al., 1983
ab-crystalline Hauck et al., 2005;
Steiner et al., 2006
Albumin Adler and Edwards. 2000,
Duncan et al., 2006
S antigen Adler et al., 1988
Purprin Schubert and LaCorbiere, 1985
Glycosaminoglycans
Chondroitin sulfate Srramm et al., 1989 Chondroitin 4-sulfate Hageman and Johnson, 1991
Chondroitin 6-sulfate Hageman and Johnson, 1987;
Porrello et al., 1989
Heparan sulfate Srramm et al., 1989 Heparan sulfate Clark et al., 2011
Keratan sulfate Srramm et al., 1989 ー
Dermatan sulfate Sobel and Ahmed, 2001 Dermatan sulfate Clark et al., 2011
Hyaluronan Hubmacher and Apte, 2013 Hyaluronan Clark et al., 2011
(continued on next page)
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Table 1 (continued )
Proteins Extracellular matrix Interphotoreceptor matrix
References References
Proteoglycans
Chondroitin sulfate proteoglycan Iozzo and Murdoch, 1996 Chondroitin sulfate proteoglycan Varner et al., 1987;
Tawara et al., 1988,
Keenan et al., 2012
Heparan sulfate proteoglycan Iozzo and Murdoch, 1996 Heparan sulfate proteoglycan Keenan et al., 2012
Keratan sulfate proteoglycan Iozzo and Murdoch, 1996 (Perlecan, Agrin, Collagen XVIII)
Dermatan sulfate proteoglycan Iozzo and Murdoch, 1996
SPACRCAN Acharya et al., 2000
Proteoglycan core proteins
Hyalectan family members
(versican, aggrecan, brevican)
Keenan et al., 2012
Short keicine-rich repeat
proteoglycan family members
(decorin, biglycan, lumican, mimecan,
prolargin, opticin, ﬁbromodeulin)
Keenan et al., 2012
Others (CD44v3, HAPLN1, HAPLN4) Keenan et al., 2012
MO-225-binding proteoglycans Yamagata et al., 1987
PG-M/versican (MY-174-binding) Zako et al., 1997
Others
Vitamin A Adler and Martin, 1982
Fatty acid BAzan et al., 1985,
Chen et al., 1996
(palmitic acid, stearic acis, palmitoleic
acid, oleic acid, linoleic acis,
docosahexaenoic acid)
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In early attempts to study the IPM biochemically, gentle saline
rinses of the outer retinal surface were used to remove soluble IPM
molecules for subsequent biochemical analyses (Berman, 1969;
Adler and Severin, 1981; Plantner, 1992a). Using such procedures,
interphotoreceptor matrix retinoid binding protein (IRBP)
(Wortman and Freeman, 1962; Pfeffer et al., 1983), a variety of
enzymes (Adler, 1989), mucins (Adler and Kulcznik, 1982; Plantner
et al., 1998a; Plantner,1992b), and immunoglobulins (Hageman and
Johnson, 1991) were successfully isolated from the IPM. Later, the
presence of a relatively insoluble IPM complex was documented in
studies of isolated Xenopus (Wood et al., 1984) and rat retina
(Porrello and LaVai, 1986).
A method for isolation of the insoluble components of the IPM
was originally developed by Johnson and Hageman (1989, 1991) for
the purpose of extracting the cone matrix components, termed the
“cone sheath” from the bovine retinas. They reported that the
insoluble components of the IPM (“cone sheath”) in bovine eyes
could be isolated as an intact layer by gently shaking isolated ret-
inas in distilled water, a method known as the “aqueous extraction
technique” (Johnson and Hageman, 1991). Using this procedure,
Hollyﬁeld et al. (1990a, 1990b) reported that highly organized,
interconnected IPM components are present throughout subretinal
space of the human retinas, and that PNA and WGA speciﬁcally
labeled cone- and rod-associated IPM components, respectively.
Distilled water detaches the IPM components from the outer retina
because the insoluble IPM becomes hydrated and swollen in the
absence of salts (Hollyﬁeld et al., 1990a, 1990b). Ishikawa et al.
(1996, 2009) isolated the IPM sheet from the bovine retina using
acidic HEPES buffer solution (pH 2.0). After treatment with 1.0%
Triton X-100, they extracted the insoluble components of the IPM
without any contaminations from the IPM sheet. A thirdmethod for
isolating the insoluble IPM involves rinsing of the outer retina with
high pH buffer, which disrupts the interactions that stabilize the
insoluble IPM (Acharya et al., 1998).The cone sheaths appear to be structurally distinct entities
within the IPM, and have been identiﬁed in the human (Steinberg
et al., 1977), monkey (Anderson and Fisher, 1979), and porcine
(Braekevelt, 1983) retinas. However, the feline cone sheath is not
similar to those shown in the human or porcine retina (Steinberg
and Wood, 1974; Pfeffer and Fisher, 1981; Fisher and Steinberg,
1982). The cat cone sheaths are formed by elaborate sheet-like
processes that emanate from the apical surfaces of RPE cells and
wrap concentrically around the cone outer segments.
The rod associated matrix in most species is very thin and
difﬁcult to distinguish by lectin-labeling of the plasma membrane
when seen in tissue section. The presence of the WGA-labeled rod
associated matrix was conﬁrmed in the human IPM materials
separated from the rest of the retina according to the speciﬁc lectin-
labeling method mentioned above (Hollyﬁeld et al., 1990b).
2.2. Soluble components of the IPM
Saline lavages of bovine IPM contain a high proportion of pro-
tein (98%) compared to glycosaminoglycan (2%) including chon-
droitin sulfate and hyaluronan (Adler and Severin, 1981; Adler and
Klucznik, 1982). The most abundant protein in the IPM is IRBP
(Bridges,1985). In addition to IRBP, the presence of other proteins in
the IPM has been reported (Hageman and Johnson, 1991).
2.2.1. IRBP
IRBP is the major soluble glycoprotein secreted by photore-
ceptor cells (Gonzalez-Fernandez et al., 1984; van Veen et al., 1986),
and has been well characterized (Wortman and Freeman, 1962;
Pfeffer et al., 1983; Chader and Wiggert, 1984; Gonzalez-
Fernandez et al., 1985; Hollyﬁeld et al., 1985). IRBP, which ac-
counts for approximately 5% of the total soluble IPM protein in the
bovine eyes (Adler and Evans, 1983), is distributed within the IPM
in a light-dependent manner, indicating intimate interactions be-
tween the IPM components and the photoreceptor cells (Uehara
et al., 1990) (Fig. 2). A large amount of IRBP is removed by wash
out with saline solution, while it has been recently reported that
wash-resistant IRBP co-localizes in the IPM immediately
Fig. 2. Light micrographs of polyester wax-embedded sections stained using anti-IRBP antibody. IRBP immunoreactivities are examined in the IPMs of albino rat eyes taken either in
the light (one or more hours into the light cycle) (left photograph) or in the dark (two or more hours into the dark cycle) condition (right photograph). a: the interface with the RPE.
b: the junction of inner and outer segments. In the retina taken in the light (left photograph), there is a strong concentration of densely stained IPM in the apical outer segment zone
(a, at the interface with the RPE) and in the basal outer segment zone (b, at the junction with the inner segments). In the dark-adapted retina (right photograph), the interstitial zone
is much more intensely stained with antibody than in the light-adapted retinas. There is no strong labeling around apical and basal region of the outer segment.
These ﬁgures are the copy of Fig. 1G and H of the manuscript by Uehara et al., 1990. (by courtesy and approval of AAAS as the copyright holder)
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(Garlipp et al., 2012, Garlipp and Gonzalez-Fernandez, 2013).
2.2.2. Other soluble proteins
Adler and Klucznik (1982) provided the ﬁrst evidence for saline
soluble mucin-like glycoproteins in the IPM. The mucins associated
with the IPM were more completely examined by Plantner et al.
(1998a, 1998b). Other saline soluble proteins include a variety of
enzymes such as acid phosphatase (Adler, 1989), cathepsin D
(Schmidt et al., 1988), arylsulfatase (Hayasaka et al., 1981), cyclic
guanosine monophosphate phosphodiesterase (Barbehenn et al.,
1985), neuron-speciﬁc enolase (Li et al., 1995), MMP (Jones et al.,
1994; Padgett et al., 1997; Plantner and Quinn, 1997) and its in-
hibitor (TIMP) (Padgett et al., 1997; Plantner et al., 1998a) and acid
hydrolase (b-galactosidase, N-acetyl-beta-glucosaminidase, a-
fucosidase, b-glucuronidase, a-glucosidase, cathepsin D, a-man-
nosidase, b-glucosidase, acid phosphatase, and acid lipase) (Adler,
1989), growth factors such as pigment epithelium-derived factor
(PEDF) (Tombran-Tink et al., 1991; Wu et al., 1995; Becerra et al.,
2004), tumor-growth factor (TGF-b) (Tan et al., 2009), basic ﬁbro-
blast growth factor (Hageman et al., 1991), insulin-like growth
factor (Waldbillig et al., 1991), inhibin (Ying et al., 1995), ab-crys-
talline (Hauck et al., 2005; Steiner et al., 2006), ﬁbulins (Hubmacher
and Apte, 2013), complement factor H (CFH) (Chen et al., 2007),
albumin (Adler and Edwards, 2000; Duncan et al., 2006), S antigen
(Adler et al., 1988), and purpurin (Schubert and LaCorbiere, 1985).
Additionally, there are a number of IPM components identiﬁed
by proteomic analysis of the porcine interphotoreceptor matrix
(Hauck et al., 2005). Although the identiﬁed proteins included
several already known in the IPM, the majority had not been pre-
viously described in this structure (Hauck et al., 2005). These
include a set of potentially neuroprotective proteins such as
phosphoprotein enriched in astrocytes 15, peroxiredoxin 5, 78 kDa
glucose-regulated protein, protein disulﬁde-isomerase, and brain-
speciﬁc polypeptide PEP-19, and a set of cell adhesive proteins
including ﬁbronectin, laminin, and thrombospondin, which have
not been previously associated with the IPM (Hauck et al., 2005).
However, there is the possibility that the IPM preparations were
contaminated with intracellular proteins from adjacent cells that
were disrupted during the isolation procedure (Hauck et al., 2005).
2.2.3. Glycosaminoglycan
Biochemical analyses detected glycosaminoglycans in the
aqueous soluble fraction of bovine IPM. Of the glycosaminoglycansisolated, 60% are chondroitin sulfates and 15% are hyaluronan
(Berman and Bach,1968;Wortman,1959; Morris et al., 1987). These
soluble glycosaminoglycans are enzymatically digested fragments
of extracted glycosaminoglycans from the insoluble fraction of IPM
(Morris et al., 1987).
2.3. Insoluble components of the IPM
Many of the IPM components are insoluble in aqueous buffers.
Themain insoluble components of the IPM are glycosaminoglycans,
proteoglycans, and hyaluronic acid (hyaluronan) (Acharya et al.,
2000; Hageman and Johnson, 1991).
2.3.1. Glycosaminoglycan
Glycosaminoglycans are large carbohydrates that are composed
of repeated disaccharide units and that occur in ﬁve main forms:
chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan
sulfate, and hyaluronan. Hyaluronan is unique among the glycos-
aminoglycans, because it does not contain any sulfate. The
glycosaminoglycan chains on the protein core are unbranched
polysaccharide chains composed of repeating disaccharide units.
These can be divided further into sulfated (chondroitin sulfate,
heparan sulfate, and keratan sulfate) and non-sulfated (hyalur-
onan) glycosaminoglycans (Schaefer and Schaefer, 2010). These
molecules are extremely hydrophilic, and adopt highly extended
conformations. The multiple biological functions of glycosamino-
glycans mainly result from their ability to interact with many
different proteins including growth factor, growth factor receptors,
chemokines, proteases, and enzyme inhibitors (Lindahl and Li,
2009; Kresse and Schonherr, 2001). Therefore, it is important to
have a detailed understanding of which glycosaminoglycans are
present in the human IPM. In the adult human eyes, immuno-
positive reactions for chondroitin sulfate, heparan sulfate, derma-
tan sulfate, and hyaluronan were present in the IPM (Clark et al.,
2011). However, keratin sulfate was not detected (Clark et al.,
2011).
A large proportion of the IPM is composed of chondroitin 4-
sulfate and 6-sulfate, which are differentially distributed within
the IPM (Hageman and Johnson, 1987; Porrello et al., 1989).
Chondroitin 4-sulfate is distributed uniformly throughout the IPM,
while chondroitin 6-sulfate is speciﬁcally associated with cone
matrix sheaths in the primate retina (Hageman and Johnson, 1991).
In contrast, Hollyﬁeld et al. (1999) reported that strong labeling of
the bovine and human IPM with 3B3 antibody (speciﬁc for
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did not observe any staining with either 1B5 antibody (recognizing
unsulfated chondroitin sulfate) or 2B6 antibody (speciﬁc for
chondroitin 4-sulfate). However, Clark et al. (2011) reported
different labeling of the human IPMwith the same anti-chondroitin
sulfate antibodies as previous study (Hollyﬁeld et al., 1999). They
found that anti-chondroitin 4-sulfatewhole-chain antibody (LY111)
positively bound to the rod and cone IPMs (Clark et al., 2011).
Additionally, they observed less intense immunostaining of the IPM
with chondroitin 4-sulfate antibody (2B6) as compared with
chondroitin 6-sulfate antibody (3B3) labeling.
2.3.2. Proteoglycans
Proteoglycans are composed of a core protein covalently bound
to one or more glycosaminoglycan chains, where the core protein
typically consists of multiple components with distinct structural
and binding features. Based on their glycosaminoglycan side
chains, proteoglycans are classiﬁed into the main groups described
above, i.e., chondroitin sulfate, dermatan sulfate, keratan sulfate,
and heparan sulfate proteoglycans. Hyaluronan is not found cova-
lently attached to proteins as a proteoglycan. Proteoglycans interact
with many biologically active molecules via their core protein
components, as well as their glycosaminoglycan chains. As such,
they play important roles in the interactions between cells and the
ECM, including the regulation of cell differentiation, proliferation,
adhesion and migration (Sarrazin et al., 2011; Iozzo and Schaefer,
2010). In eyes, chondroitin sulfate proteoglycans are essential in
maintaining adhesion between RPE cells and the neurosensory
retina (Lazarus and Hageman, 1992).
Histochemical analysis using cuprolinic blue revealed that
chondroitin sulfate proteoglycans are present abundantly in the
IPM (Varner et al., 1987; Tawara et al., 1988, 1989). Iwasaki et al.
(1992) revealed that the membrane-bound chondroitin sulfate
proteoglycans existed in the cell membrane of the RPE. An addi-
tional chondroitin sulfate-containing proteoglycan, identiﬁed by
the monoclonal antibody MO-225 (Yamagata et al., 1987) and MY-
174 (Zako et al., 2002), is localized at the interface between the RPE
and the neural retina.
Proteoglycans are also divided into families based on the
structural features of their core protein. In the early 1990s, genes for
core proteins of proteoglycans, such as neurocan core protein
(NCAN) and phosphocan core protein (PTPRZ1), were cloned. The
core proteins were characterized, and shown to play important
roles in the development and maintenance of neural networks
(Oohira et al., 1994; Margolis et al., 1996). Reﬁnement of molecular
biological studies on proteoglycans enabled investigation into the
signiﬁcance of these ECM constituents in developing and injured
tissues and/or cultured cells (Oohira et al., 1994; Margolis et al.,
1996).
Recently, Keenan et al. (2012) have reported the distribution of
proteoglycans in the adult human retina. They identiﬁed heparan
sulfate proteoglycans (perlecan, agrin, collagen XVIII), hyalectan
family members (versican, aggrecan, brevican), and short leucine-
rich repeat proteoglycan family members (decorin, biglycan,
lumican, mimecan, prolargin, opticin, ﬁbromodulin) in the human
IPM. However, the precise functions of these proteoglycans remain
to be elucidated.
Lazarus and Hageman (1992) intravitreally injected xyloside, an
inhibitor of chondroitin sulfate proteoglycan synthesis, and
demonstrated that perturbation of chondroitin sulfate proteogly-
can could induce cone photoreceptor cell outer segment degener-
ation and shallow retinal detachment. These results indicate that
adhesion between the neural retina and the RPE is dependent on
continuous synthesis of cone matrix sheath-associated pro-
teoglycans (Lazarus and Hageman, 1992).2.3.3. Glycoproteins and proteoglycans associated with hyaluronan
Hyaluronan is a component of non-covalently formed com-
plexes with proteoglycans in the ECM. Hyaluronan polymers are
very large (with molecular weights of 100,000e10,000,000) and
can displace a large volume of water. This property makes them
excellent lubricators and shock absorbers. Using a speciﬁc probe for
hyaluronan (biotinylated hyaluronan binding complex, bHABC),
Hollyﬁeld et al. (1998) identiﬁed that, with the exception of the
mouse, hyaluronan is a prominent constituent of the IPM in human,
bovine, guinea pig, dog, and rat retinas. Hyaluronan-binding motifs
on these cells provides the structural link between the neural retina
and the RPE (Hollyﬁeld, 1999; Inatani and Tanihara, 2002). Hya-
luronan is a widely distributed glycosaminoglycan, and is a major
insoluble component of the IPM. It is secreted from the apical side
of the RPE (Senanayake et al., 2001), where it is believed to function
as the primary scaffold material in the IPM (Feeney, 1973). Becerra
et al. (2008) revealed that PEDF has binding afﬁnity for hyaluronan.
PEDF is secreted apically from the RPE, and has HA binding motifs.
PEDF is responsible for avascularity of the IPM and survival of
photoreceptors (Becerra, 2006; Broadhead et al., 2010). Abnormal
localization of hyaluronan could lead to IPM degeneration, subse-
quently affecting photoreceptor survival (LaVail et al., 1981).
Indeed, it has been demonstrated that the IPM is abnormally
distributed in the Royal College of Surgeons (RCS) rat model for
retinal degeneration (RCS rats) (LaVail et al., 1981).
Biochemical studies have clearly documented that hyaluronan is
related to sialoprotein associated with cones and rods (SPACR) and
sialoproteoglycan associated with cones and rods (SPACRCAN). The
gene interphotoreceptor matrix proteoglycan-1 (IMPG1) encodes
SPACR that is predominantly expressed by rod and cone photore-
ceptor cells (Acharya et al., 1998). Tien et al. (1992) previously re-
ported that wheat germ agglutinin (WGA) predominantly binds to
147 kD proteins in the matrix components surrounding rods in the
human retina. Later, Acharya et al. (1998) isolated and puriﬁed
SPACR from the human IPM by lectin afﬁnity chromatography.
However, Northern and dot-blot analyses, as well as the isolation of
expressed sequence tags, demonstrate that IMPG1 mRNA is
expressed not only in the neural retina but also in several other
non-ocular tissues including human lung, thymus, kidney, and
small intestine (Kuehn and Hageman, 1999). SPACR is the major
147e150 kD glycoprotein present in the insoluble IPM surrounding
rod and cone photoreceptor cells in the human retina (Hollyﬁeld
et al., 1990b; Acharya et al., 1998, 2000; Lee et al., 2000).
The gene interphotoreceptor matrix proteoglycan-2 (IMPG2)
encodes SPACRCAN, a proteoglycan that binds chondroitin sulfate
and hyaluronan (Acharya et al., 2000). Analysis of IMPG2mRNA and
SPACRCAN protein revealed that SPACRCAN is expressed exclu-
sively by photoreceptor cells in the retina and pinealocytes in the
pineal gland (Foletta et al., 2001). SPACRCAN plays a role in the
organization of the IPM and may promote the growth and main-
tenance of the light-sensitive photoreceptor outer segment
(Acharya et al., 2000; Foletta et al., 2001).
The core proteins of SPACR and SPACRCAN have hyaluronan-
binding motifs of the receptor for hyaluronan-mediated motility
(RHAMM) type (Hollyﬁeld, 1999; Inatani and Tanihara, 2002)
(Fig. 3). Additionally, mutation of RP-1 gene, encoding oxygen-
regulated protein 1, is associated with autosomal dominant reti-
nitis pigmentosa (Guillonneau et al., 1999). The deduced sequence
of the ORP-1 polypeptide contains 14 putative HA-binding motifs
and 11 putative glycosaminoglycan-attachment sites. If ORP-1 is
associated with the plasma membrane of photoreceptors, as is
predicted from its deduced sequence, the HA-binding motifs and
glycosaminoglycans on this molecule would also be positioned to
interact with the HA scaffold (Hollyﬁeld, 1999).
Fig. 3. Cartoon depicting the levels of organization of hyaluronan (HA), which forms the basic IPM scaffold, drawn by David Schumick, Medical Illustrator at The Cleveland Clinic
Foundation. Left panel shows the alignment of linear HA molecules forming the basic matrix scaffold structure. Center panel depicts the 3D scaffold complex in the extracellular
compartment adapted from electron microscope images of the IPM. Right panel depicts the interaction of the scaffold with HA-binding motifs on cells that border the IPM (CD44 on
apical microvilli of Müller cell and RHAMM on apical RPE processes) and secreted molecules within the IPM (SPACR, SPACRCAN; Pigment Epithelium-Derived Factor [PEDF], and
IRBP).
These ﬁgures are the copy of Fig. 1 of the manuscript by Hollyﬁeld, 1999. (by courtesy and approval of the Association for Research in Vision and Ophthalmology as the copyright
holder)
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A few other constituents have been identiﬁed within the IPM.
These include vitamin A (Adler and Martin, 1982) and a variety of
fatty acids (BAzan et al., 1985). Vitamin A is essential for vision
because one of its metabolites, 11-cis-retinal, serves as the chro-
mophore for the visual protein rhodopsin (Saari, 1994). Continuous
shuttling of retinoids between photoreceptor and pigment
epithelium cells across the IPM is a critical part of the visual cycle
(Saari, 1994). The transport of retinoids in the IPM is believed to be
mediated by IRBP (Pepperberg et al., 1993), a protein that, in
addition to possessing two retinoid-binding sites, associates in vivo
with long chain fatty acids (Fong et al., 1984; Lin and Clegg, 1998;
Gonzalez-Fernandez et al., 2009). IRBP facilitates the removal of
11-cis-retinal by releasing it from the RPE membranes (Edwards
and Adler, 2000).
IRBP also functions as an intercellular fatty acid carrier (BAzan
et al., 1985). The fatty acid composition of bovine IPM is similar
to the composition of fatty acids endogenously bound to bovine
IRBP (Chen et al., 1996). Chen et al. (1996) found that themajor fatty
acids associated with bovine IRBP were palmitic (26.6%), stearic
(13.5%) acid, oleic (29.4%) acid, arachidonic acid (7.7%), and doco-
sahexaenoic acid (8.6%). They also found that docosahexaenoic acid
induced a rapid and speciﬁc release of 11-cis-retinal from one of the
retinoid-binding sites of IRBP (Chen et al., 1996). Later, Semenova
and Converse (2003) reported that the bovine IPM was rich in
oleic acid, and it bound much more strongly than did docosahex-
aenoic acid to IRBP.
Taken together, the IPM is a specialized form of the ECM for the
communication between photoreceptor cells and the RPE. It is
comprised of characteristic soluble PEDF, SPACR, IRBP, and insol-
uble SPACRCAN, vitamin A as summarized in Table 1. Table 2 is a list
of the above mentioned components reported to date in the IPM
including information about functional relevance.3. IPM and retinal degenerative disorders
A few gene encoding proteins that are localized to the IPM are
associated with human inherited retinal diseases (Bandah-
Rozenfeld et al., 2010). These included IRBP (den Hollander et al.,
2009) and IMPG2 (Bandah-Rozenfeld et al., 2010) causing
autosomal-recessive retinitis pigmentosa (RP), IMPG1 causing
autosomal-dominant and -recessive forms of Best disease (Manes
et al., 2013a,b), inhibitor of metalloproteinases-3 (TIMP3) causingSorsby's fundus dystrophy (Weber et al., 1994), and EGF-containing
ﬁbulin-like extracellular matrix protein 1 (EFEMP1) causing Doyne
honeycomb retinal dystrophy (Marmorstein et al., 2002). Addi-
tionally, there are a number of candidate molecules among the
constituents of the IPM with potential relevance to age-related
macular degeneration (AMD).3.1. Retinitis pigmentosa
RP is the most common subtype of retinal degeneration and is
responsible for loss of vision in one in 4000 people worldwide
(Hartong et al., 2006). RP can result from defects in any of more
than 60 genes inherited as autosomal dominant (30%e40% of
cases), autosomal recessive (50%e60%), or X-linked (5%e15%).
Despite the heterogeneous genetic origin, RP patients display
common clinical hallmarks, such as an abnormal, bone-spicule
dark, punctuate pigmentation, typical of a thinned, degenerate
retina; attenuated retinal vessels; dysfunction of the photorecep-
tors or the retinal pigment epithelium (RPE), marked by diminished
electroretinogram (ERG) responses of both rods and cones, and
progressive photoreceptor death (Petrs-Silva and Linden, 2014.). In
most cases, rods are affected ﬁrst, leading to night blindness, pe-
ripheral visual ﬁeld loss leading to tunnel vision, and eventual total
blindness. In a few cases, cones are affected ﬁrst, causing loss of
central vision.
The most common mutations associated with autosomal
dominant RP are in either the RHO or the RDS/peripherin gene,
which account for approximately 25% and 10% of the cases,
respectively (Petrs-Silva and Linden, 2014).
Recently, a mutation leading to an Asp-to-Asn substitution at
position 1080 (D1080N) in RBP3 (IRBP gene) has been found in
patients with autosomal recessive retinitis pigmentosa (den
Hollander et al., 2009). Patients with the mutation displayed pro-
found loss of rod photoreceptor function and severely diminished
cone photoreceptor function (den Hollander et al., 2009). Li et al.
(2013) indicated two possible mechanisms of the disease using
the mouse photoreceptor-derived 661W cells and 293T-LC cells,
indicated two possible mechanisms of the disease: (i) loss of
normal secretion of IRBP from retinal cells, and (ii) cytotoxic
function causing abnormalities of the endoplasmic reticulum
stress. Mutations in IMPG2 also cause autosomal-recessive RP
(Bandah-Rozenfeld et al., 2010). Most patients with IMPG2 muta-
tions showed an early-onset form of the disease with progressive
visual-ﬁeld loss and deterioration of visual acuity due to the
Table 2
IPM components and their physiological roles.
Proteins Function
1 Fibrous protein
Fibulin Incorporated into the IPM scaffold
3 Enzymes
MMP Zinc-dependent endopeptidase involved in the IPM degradation
TIMP Inhibitor of matrix metalloproteinases
cGMPP Associated with the phototransduction cascade
b-glucuronidase Involved in the lysosomal degradation of chondroitin sulfate and other
beta-glucuronide-containing proteoglycans
Acid phosphatase Participate in digesting shed outer segments and in catabolizing IPM components
Cathepsin D
Other acid hydrolase
(beta-galactosidase, N-acetyl-beta-glucosaminidase,
a-fucosidase, b-glucuronidase, a-glucosidase,
a-mannosidase, b-glucosidase, acid lipase）
Arylsurfatase
Neuron-speciﬁc enolase Survival factor for the photoreceptor cells
4 Growth factor and receptor
TGF-b Growth factor involved in proliferation and differentiation of the IPM
PEDF Growth factor with neurotrophic and anti-angiogenic properties
FGF Growth factor involved in mitogenesis, angiogenesis and cell survival
IGF Growth factor involved in cell growth and development
Inhibin Growth factor and trophic factor for photoreceptors and RPE
6 Hyaluronan-binding proteins
Sialoprotein associated with cones and rods (SPACR) Stabilize the basic scaffold of the IPM with hyaluronan
Oxygen-regulated photoreceptor protein (ORP) Stabilize the basic scaffold of the IPM with hyaluronan
7 Others
CFH Inhibitor of the complement pathway
Mucin Stabilize the basic scaffold of the IPM with hyaluronan
IRBP Vitamin A trafﬁcking in visual cycle
ab-crystalline Molecular chaperone, cytoprotection
Albumin Forming stable complexes with the retinoids of the visual cycle
S antigen Rapid and reproducible shutoff of rhodopsin signaling
Purprin Vitamin A trafﬁcking in visual cycle
Glycosaminoglycans
Chondroitin 4-sulfate Insoluble component of both rod and cone IPM.
Chondroitin 6-sulfate Major insoluble component of the cone sheath.
Heparan sulfate Associated with cell adhesion
Dermatan sulfate
Hyaluronan Major component of the IPM
Proteoglycans
Chondroitin sulfate proteoglycan Related to adhesion between the RPE and photoreceptors
Heparan sulfate proteoglycan
SPACRCAN Stabilize the basic scaffold of the IPM with chondroitin sulfate and hyaluronan
PG-M/versican Associated with hyaluronan
Hyalectan family members (versican, aggrecan, brevican)
Short keicine-rich repeat proteoglycan family members
(decorin, biglycan, lumican, mimecan, prolargin, opticin,
ﬁbromodeulin)
Others (CD44v3, HAPLN1, HAPLN4)
MO-225-binding proteoglycans Associated with chondroitin sulfate proteoglycan
Others
Vitamin A Transport across the IPM by IRBP
Fatty acid Transport across the IPM by IRBP
(palmitic acid, stearic acis, palmitoleic acid, oleic acid,
linoleic acis, docosahexaenoic acid)
M. Ishikawa et al. / Experimental Eye Research 133 (2015) 3e1810maculopathy (Bandah-Rozenfeld et al., 2010). The IMPG2 gene en-
codes the IPM proteoglycan, SPACRCAN, which is an insoluble
constituent of the IPM (Bandah-Rozenfeld et al., 2010).3.2. Vitelliform macular dystrophies
Vitelliform macular dystrophies (VMD) are inherited retinal
dystrophies characterized by yellow, round deposits visible upon
fundus examination and encountered in individuals with juvenile
Best macular dystrophy (BMD) or adult-onset vitelliform macular
dystrophy (AVMD) (Blodi and Stone, 1990). Although many BMD
and some AVMD cases harbor mutations in BEST1 (Kr€amer et al.,
2000) or PRPH2 (Seddon et al., 2001), the underlying geneticcause remains unknown for many affected individuals.
Recently, mutations in IMPG1 encoding the SPACR protein have
been shown to cause autosomal-dominant and -recessive forms of
Best disease (Manes et al., 2013a,b).3.3. Sorsby's fundus dystrophy
Sorsby's fundus dystrophy (SFD), an autosomal dominant con-
dition, provides an excellent Mendelian model for the study of
AMD, the most common genetically complex maculopathy in the
elderly. Weber et al. (1994) mapped the SFD locus to 22q13-qter
containing the gene for tissue inhibitor of metalloproteinases-3
(TIMP3), which is known to play a pivotal role in extracellular
M. Ishikawa et al. / Experimental Eye Research 133 (2015) 3e18 11matrix remodeling. They identiﬁed point mutations in the TIMP3
gene in affected members of two SFD pedigrees.
3.4. Doyne honeycomb retinal dystrophy
Doyne honeycomb retinal dystrophy is an autosomal dominant
disease that is characterized by yellowewhite drusen deposits that
accumulate beneath the RPE (Stone et al., 1999). This disorder has
symptoms quite similar to those of AMD: neovascularization in the
macular region and progressive loss of central vision (Marmorstein
et al., 2002).
Although the precise function and possible role in AMD devel-
opment have not been fully characterized, mutations in the EFEMP
1 gene are associated with Doyne honeycomb retinal dystrophy.
Fibulin 3, encoded by the EFEMP 1 gene, is secreted from RPE cells
and localizes in the IPM (Marmorstein et al., 2002).
3.5. AMD
AMD is a leading cause of blindness that affects the macular
region of elderly individuals (Friedman et al., 2004). The changes
occurring in AMD are ﬁrst reﬂected in structures at the basal side of
the RPE, Bruch membrane, and the choriocapillaris (Campochiaro
et al., 2006). The clinical appearance of AMD is characterized by
drusen formation between the RPE and Bruch's membrane, RPE
changes, and choroidal neovascularization (CNV) (Kasuga et al.,
2011). AMD can be classiﬁed into early and late phases (Kasuga
et al., 2011). Following the early appearance of drusen and RPE
changes, the early phase is characterized by large yellow subretinal
deposits called drusen and RPE changes. The disease can progress
to either CNV, a rapidly deteriorating late form of AMD character-
ized by new blood vessels that invade the macula (wet AMD), or to
geographic atrophy (dry AMD), a slower, late onset form that causes
degeneration of the RPE in the macula. Although the pathogenesis
of AMD still remains unknown, transcriptome analysis of the retina
and choroid in an accelerated-aging rat model shows substantial
changes in expression of ECM genes and ECM turnover genes
(Kozhevnikova et al., 2013). Based on these ﬁndings, here we
examine candidate molecules among the constituents of the IPM
with potential relevance to AMD.
Most of the soluble components of the IPM are secreted by the
RPE, which contributes to the maintenance of the microenviron-
ments of the IPM and the Bruch membrane (Kay et al., 2013). It is
becoming apparent that protein secretion by the RPE is a highly
regulated process, and the abnormalities in this process could lead
to incorrect expression of essential growth factors and structural
proteins in the extracellular space (Kay et al., 2013). A recent study
(An et al., 2006) has demonstrated that RPE cell cultures derived
from patients with AMD display a striking difference in the secre-
tion of several proteins compared with matched healthy donors. An
et al. (2006) used stable isotope labeling by amino acids in cell
culture in combination with tandem mass spectrometry analysis
and ZoomQuant quantiﬁcation to assess differential protein
secretion by RPE cell cultures. Interestingly, RPE cells from autop-
sied AMD donors secreted 2- to 3-fold more MMP-2 protein than
those from autopsied age-matched healthy donors. By contrast,
secretion of PEDF, an endogenous inhibitor of angiogenesis in the
eye (Holekamp et al., 2002), surprisingly, was also increased in RPE
cells from the AMD patients (An et al., 2006). Correspondingly, it
has been reported that PEDF is deﬁcient in the vitreous of wet AMD
patients (Holekamp et al., 2002).
ab crystallin is a molecular chaperone that is a soluble compo-
nent of the IPM (Hauck et al., 2005; Steiner et al., 2006), and has
been detected in the RPE of patients with early and advanced AMD
(De et al., 2007). It is induced by stress stimuli and has also beenlinked to wet AMD pathogenesis (De et al., 2007). Because of this,
expression of ab crystallin has been proposed as a possible
biomarker for the disease. Under severe oxidative stress, the RPE
barrier can become compromised, and ab-crystallin becomes
aggregated on the basal side of the RPE (Sreekumar et al., 2010),
resulting in the formation of the drusen (De et al., 2007). ab-crys-
tallin was detected in the RPE of patients with early and advanced
AMD.
PEDF is secreted apically into the IPM by the RPE, and thus
constitutes a part of the IPM surrounding photoreceptor outer
segments (Tombran-Tink et al., 1991; Wu et al., 1995; Becerra et al.,
2004). Decreased levels of the secreted PEDF which occur in the
DKOrd8mousemodel of AMD relative to wild type are IPM relevant
(Wang et al., 2013). Administration of PEDF reduces apoptosis and
pro-inﬂammatory cytokine gene expression in a murine model of
focal retinal degeneration (Wang et al., 2013). Additionally, a sig-
niﬁcant decrease in the PEDF plasma level in patients with the dry
form of AMD was found (Machalinska et al., 2012). In contrast, for
wet AMD there is a strong positive correlation between plasma
concentrations of vascular endothelial growth factor (VEGF) and
PEDF. Further there are signiﬁcantly higher PEDF and VEGF plasma
levels in patients with bilateral manifestations of the disease in
comparison with non-AMD healthy control (Machalinska et al.,
2012).
In contrast, VEGF is one of the most potent angiogenic stimu-
lators (Cross and Claesson-Welsh, 2001). Inappropriate expression
levels of PEDF and VEGF are associated with neovascularization
(Ozawa et al., 2004; Kolomeyer et al., 2011; Machalinska et al.,
2012). Steinle et al. (2008) characterized age-related changes in
PEDF and VEGF in rat retina. Increase in VEGF and its receptor VEGF
receptor type 2 (VEGFR2), and simultaneous decrease in PEDF were
found in aged rats. These results indicate that the normal aging
retina is at increased risk for neovascular changes. A critical balance
appears to exist between PEDF and VEGF, with PEDF counteracting
the angiogenic potential of VEGF. A decrease in PEDF may disrupt
this balance and create a permissive environment for the formation
of CNV in AMD. Consistent with these observations, Lin et al. (2008)
indicated that serpin peptidase inhibitor, clade F (alpha-2 anti-
plasmin, pigment epithelium derived factor) (SERPINF1) gene
encoding PEDF gene polymorphisms contribute to AMD.
Both PEDF and VEGF are secreted by the RPE, but in opposite
directions (Kay et al., 2013). Thus PEDF is secreted primarily to the
apical side to support retinal neurons and photoreceptors
(Tombran-Tink et al., 1991; Wu et al., 1995; Becerra et al., 2004). In
contrast, VEGF is primarily secreted to the basal side of the RPE for
maintenance of the choriocapillaris and choroidal vessels (Roberts
and Palade, 1995; Yokomori et al., 2003; Maminishkis et al., 2006;
Saint-Geniez et al., 2009; Sonoda et al., 2009; Ablonczy et al.,
2011; Ford and D'Amore, 2012). However, VEGF also has neuro-
protective effects for retinal neurons (Kilic et al., 2006; Nishijima
et al., 2007). Such directional secretions of VEGF and PEDF by the
RPE play an important role in the development of the AMD. Sonoda
et al. (2009) indicated that loss of RPE polarity in advanced AMD
results in remarkable loss of neurotrophic and vascular support for
the outer retina, potentially leading to photoreceptor degeneration.
CD44 is a hyaluronan-binding protein present in the plasma
membrane of Müller cell microvilli, which borders the IPM (Chaitin
et al., 1994). The interaction of hyaluronan with the receptor CD44
has been associated with choroidal neovascularization, a common
symptom of wet AMD (Mochimaru et al., 2009). Inhibition of the
hyaluronaneCD44 interaction leads to signiﬁcant suppression of
inﬂammation-related CNV (Mochimaru et al., 2009). In contrast,
genetic ablation of CD44 signiﬁcantly augmented CNV formation
together with hyaluronan accumulation and macrophage inﬁltra-
tion, compared with wild-type mice (Mochimaru et al., 2009).
Table 3
A comparison of IPM components between human and rodent models for retina diseases.
Human Animal model
Proteins Reference Reference
1 Fibrous protein
Fibulin EFEMP 1 gene encoding ﬁbulin
were associated with Doyne
honeycomb retinal dystrophy.
Marmorstein et al., 2002
2 Enzymes
MMP MMP-9 Rs3918242 (C -> T)
single nucleotide
polymorphism played a
signiﬁcant role in the
development of AMD.
Liutkevicien _e et al., 2012 In mice deﬁcient in MMP-9
expression, the development of
choroidal neovascularization
induced by laser
photocoagulation still occurred.
Fiotti et al., 2005
TIMP Point mutations in the TIMP3
gene was found in affected
members of two Sorsby's
fundus dystrophy pedigrees.
Weber et al., 1994
cGMPP Mutations in the gene encoding
the b subunit of cGMP
phosphodiesterase were found
in human patients suffering
from autosomal recessive
retinitis pigmentosa.
Dietrich et al., 2002 In rd mice which had cGMPP
defect, the structural integrity
of the cone sheath was
weakened concomitantly to the
cone photoreceptor
degeneration.
Bowes et al., 1990
b-glucuronidase In mice with b-glucosidase-
defect, mucopolysaccharidosis
type VII was induced. In these
mice, altered distribution of
chondroitin sulfate
proteoglycans was observed.
Lazarus et al., 1993
3 Growth factor
PEDF PEDF gene polymorphisms
contribute to AMD.
Lin et al., 2008
4 Hyaluronan-binding proteins
Sialoprotein associated with
cones and rods (SPACR)
Mutations in IMPG1 encoding
the SPACR protein was shown
to cause autosomal-dominant
and -recessive forms of Best
disease.
Manes et al., 2013a,b
Oxygen-regulated
photoreceptor protein (ORP)
Mutation of RP-1 gene,
encoding ORP may be
associated with autosomal
dominant retinitis pigmentosa.
Pierce et al., 1999
5 Others
IRBP Autosomal recessive retinitis
pigmentosa patients with a
mutation leading to an Asp-to-
Asn substitution at position
1080 (D1080N) in RBP3 (IRBP
gene) was reported.
den Hollander et al., 2009 ① The density of label for IRBP
at the apical RPE region was
obviously low in the rd and rds
mouse retinas.
Carter-Dawson and Burroughs,
1989
②Synthesis and secretion of
IRBP were deﬁcient in rd and
rds mouse retinas.
van Veen et al., 1989
ab-crystalline ab-crystallin was detected in
the RPE of patients with early
and advanced AMD.
De et al., 2007
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M. Ishikawa et al. / Experimental Eye Research 133 (2015) 3e18 13In summary, a number of IPM components play signiﬁcant roles
in the etiology of human and animal retinal dystrophies. Table 3
summarizes and compares these components.
4. IPM and animal models
The IPM has been investigated in several rodent models of he-
reditary retinal degeneration including the rd, rds, nr and MPS VII
mutant mice and RCS rats as well as in canine model, the prcd
miniature poodle dogs.
4.1. rd mice
Retinal degeneration (rd) mice homozygous for the rd1 muta-
tion have an early onset severe retinal degeneration (Sidman and
Green, 1965). The rd mouse, which has a cGMP phosphodies-
terase defect (Bowes et al., 1990), is an animal model for human
retinal dystrophy. The rod photoreceptors of mice with the rd1
mutation undergo apoptosis during the ﬁrst 4 weeks in vivo or in
organ culture (Ogilvie et al., 2000). Consistently, mutations in the
gene encoding the b subunit of cGMP phosphodiesterase have been
found in human patients suffering from autosomal recessive RP, a
disorder bearing phenotypic resemblance to the rdmouse (Dietrich
et al., 2002). In rd mice, the structural integrity of the cone sheath
was weakened concomitantly with degeneration of the cone
photoreceptor cells (Hageman and Johnson, 1991). A decrease in
chondroitin sulfate proteoglycans was reported in the IPM of rd
mice (Porrello et al., 1989). The ratio of heparan sulfate to chon-
droitin sulfate increased in cultured retinal neuronal cells of rdmice
(Landers and Hollyﬁeld, 1992; Landers et al., 1994). Synthesis and
secretion of IRBP were reported to be deﬁcient in rd mice retinas
(van Veen et al., 1989).
4.2. rds mice
Retinal degeneration slow (rds)mice have a gene defect located
to the peripherin locus (Connell et al., 1991). The defect is a
dominant mutation that arose spontaneously, and the phenotype is
characterized by slow degeneration of the outer nuclear layer of the
retina. Retinal degeneration begins at 5 weeks, with loss of retinal
rod photoreceptor cells by 7e10 months, and loss of cone photo-
receptor cells by 12 months of age. An increase in IPM staining with
colloidal iron around rod and cone photoreceptor cells was
observed in rds mice (Sanyal et al., 1988). The density of label for
IRBP at the apical RPE region was obviously low in the rds mice
retinas when compared to the same region in controls of the same
ages which was densely labeled for IRBP (Carter-Dawson and
Burroughs, 1989). Synthesis and secretion of IRBP were deﬁcient
in rdsmouse retinas (van Veen et al., 1989). Consistently, the IPM of
rds mice showed little cuprolinic blue staining (Tawara and
Hollyﬁeld, 1990).
4.3. nr mice
Mice that are homozygous for the nervous (nr) mutation display
a progressive development of abnormalities that affect the outer
retina (Mullen and LaVail, 1975; LaVail et al., 1993). In addition to an
overall loss of photoreceptor cells in the outer nuclear layer (ONL),
remnant photoreceptors have short and disorganized outer seg-
ments (Mullen and LaVail, 1975). The photoreceptor cells of nrmice
also display distinct subcellular changes, including pyknotic nuclei
and mitochondrial distortions (Landis, 1973a, 1973b; White et al.,
1993). Autoradiographic analysis of rod outer segment renewal
shows that outer segment membranes are synthesized in nr ho-
mozygotes (LaVail et al., 1993). Rhythmic outer segment disc
M. Ishikawa et al. / Experimental Eye Research 133 (2015) 3e1814shedding and phagocytosis by the RPE occur at approximately
normal rates in nr/nr mice (LaVail et al., 1993). Histochemical and
immunocytochemical study of the IPM reveals the exclusion of
stainable IPM from the outer segment zone by lamellar whorls of
outer segment membrane, accumulation of stainable IPM in the
basal region of the outer segment zone, and the absence of an
intense band of stainable IPM at the apical surface of the RPE (LaVail
et al., 1993). These changes in the IPM are similar to those seen in
the Royal College of Surgeons (RCS) rat (LaVail et al., 1993).
4.4. MPS VII mice
A mouse model with mucopolysaccharidosis (MPS) VII has an
inherited deﬁciency of the lysosomal enzyme b-glucuronidase,
which affects the degradation of chondroitin sulfate glycosamino-
glycan (Birkenmeier et al., 1989). The b-glucuronidase deﬁciency
results in the accumulation of large amount of non-digestible ma-
terials in the RPE. Following that, degeneration of the photore-
ceptor cells occurs.
The apical localization of chondroitin sulfate and the basal
localization of phytohemagglutinin lectin (PHA) associated carbo-
hydrate was altered in the MPS VII mouse by the fourth postnatal
month (Lazarus et al., 1993). A loss of the normal apicalebasal
distribution of chondroitin 6-sulfate and PHA-L-binding IPM pro-
teoglycans was apparent by 4 postnatal months (Lazarus et al.,
1993). In contrast, WGA-binding proteoglycan remained uni-
formly distributed through 8 months (Lazarus et al., 1993). The
distribution of PNA label remained cone speciﬁc (Lazarus et al.,
1993).
4.5. RCS rats
The retina of RCS rats has a RPE defect that affect phagocytosis of
photoreceptor outer segments (Herron et al., 1969). In normal
retina, staining of the IPMmucosubstances labeled with Alcian blue
or reaction with colloidal iron appears to begin on postnatal day 12
(LaVail et al., 1981). For the RCS rats, the intense band of IPM
staining fails to develop completely at the apical surface of the RPE.
As whorls of outer segment membranes accumulate due to the
phagocytosis failure by the RCS RPE cells, IPM staining almost
disappears at the RPE cell surface and in the debris zone (LaVail
et al., 1981). In addition, the basal outer segment region stains
much more heavily in RCS retinas than in normal retinas, a feature
that presumably represents an abnormal accumulation of IPM in
this region (LaVail et al., 1981).
Also, RCS rats displayed an absence of the IPM markers such as
WGA, Ricinus communis agglutinin, and concanavalin A on the
surface of the accumulated outer segment debris (Cohen and Nir,
1984; McLaughlin and Wood, 1980). PNA-detectable cone sheath
material remained until relatively late in the degenerative process
(Hageman and Johnson, 1991).
4.6. prcd dogs
Progressive rodecone degeneration (prcd) (Aguirre and Acland,
1988) is an autosomal recessive disease in canine. The mutant
retina exhibits a series of characteristic, sequential clinical,
morphological, and biochemical abnormalities. The photoreceptor
pathology includes elongated and irregular outer segments with
disorganized stacks of outer segment discs, and the appearance of
villiform extensions from the outer segment membrane into the
IPM, which, in cross sections, appear as vesicular proﬁles. In the
prcd miniature poodle dogs (Mieziewska et al., 1993a,b), the
photoreceptor layer degenerates slowly in the course of 5e7 years.
Before and during the course of the disease, the lectin distributionin rod and cone IPM remained normal, however, in the degenera-
tive phase of the disease, there are structural changes in the IPM.
The interconnection between the individual IPM was disrupted.
Cone and, to a lesser degreed rod IPMs were thickened around the
inner and outer segments.
5. Conclusions
Given that the IPM occupies a strategic interface between the
neural retina and the RPE, it is likely to play an important role in
maintaining retinal function by mediating biochemical and phys-
ical interaction among the photoreceptor cells, RPE, choroidal
vasculature, and Müller glia. Recent biochemical studies have
revealed that IPM components, including ﬁbulin, MMP, cGMPP,
PEDF, SPACR, ab-crystallin, and SPACRCAN, play a signiﬁcant role in
the etiology of photoreceptor degeneration. Changes ﬁrst man-
ifested in the IPM could interfere with the metabolism of the retina
and lead indirectly to RPE stimulation and the initiation of retinal
diseases. However, our understanding of the structure, composi-
tion, and function of the IPM remains minimal. Further studies are
required to identify other functional roles of the IPM components
and to determine their possible involvement as targets for treat-
ment of retinal diseases. Basic research and clinical studies should
pay substantial attention to clarifying the functional roles and
pathological meaning of the IPM.
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